What blood workup and management are recommended for a patient diagnosed with Polycystic Ovary Syndrome (PCOS) on ultrasound?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Workup and Management for PCOS Diagnosed on Ultrasound

For patients with PCOS identified on ultrasound, a comprehensive laboratory workup should include total testosterone, free testosterone, TSH, prolactin, fasting glucose/insulin ratio, 2-hour 75g OGTT, and lipid profile, with management focused on combined oral contraceptives and metformin regardless of BMI. 1

Diagnostic Considerations

It's important to note that ultrasound findings alone are insufficient for PCOS diagnosis. The Rotterdam criteria require at least two of three features:

  • Chronic anovulation (irregular menstrual cycles)
  • Hyperandrogenism (clinical or biochemical)
  • Polycystic ovaries on ultrasound 1, 2

Ultrasound Criteria for PCOS

  • ≥20 follicles (2-9mm) per ovary or ovarian volume ≥10ml 1
  • Transvaginal approach is preferred if sexually active and acceptable to the patient 3
  • For older ultrasound technology, ovarian volume ≥10ml is the threshold 3

Recommended Blood Workup

First-Line Laboratory Tests

  • Androgen Assessment:
    • Total testosterone and free testosterone using mass spectrometry (highest diagnostic accuracy) 1
    • Free Androgen Index (FAI) - 78% sensitivity, 85% specificity 1
    • Androstenedione - 75% sensitivity, 71% specificity 1
    • DHEAS - 75% sensitivity, 67% specificity 1

Exclusion of Other Disorders

  • TSH (thyroid disorders)
  • Prolactin (hyperprolactinemia)
  • 17-hydroxyprogesterone (congenital adrenal hyperplasia)
  • Consider overnight dexamethasone suppression test or 24-hour urinary free cortisol (Cushing's syndrome) 1

Metabolic Assessment

  • Fasting glucose/insulin ratio
  • 2-hour 75g oral glucose tolerance test (OGTT) - especially for BMI >25 kg/m²
  • Fasting lipid profile 1
  • HbA1c (marker of cardiovascular risk) 4

Management Approach

First-Line Treatments

  1. Oral Contraceptives:

    • Primary treatment for menstrual irregularities and hyperandrogenism
    • Regulates cycles, prevents endometrial hyperplasia
    • Lowers androgens and increases sex hormone-binding globulin 1
    • Note: May be associated with minor weight gain 4
  2. Metformin:

    • Improves insulin sensitivity and reduces androgen levels
    • Associated with minor but significant weight loss regardless of BMI 4
    • Consider for all PCOS patients, including normal weight 4
  3. Combined Approach:

    • Consider combined metformin and oral contraceptives for optimal management 4
  4. Lifestyle Modifications:

    • Low glycemic index diet
    • Regular physical activity
    • Weight loss if overweight/obese 1

Special Considerations

Pitfalls to Avoid

  • Using inappropriate testosterone assays (direct immunoassays) instead of mass spectrometry 1
  • Relying solely on ultrasound for diagnosis 1
  • Using LH/FSH ratio as diagnostic criterion (low sensitivity at 41-44%) 5
  • Failing to screen for metabolic complications 1

Age-Specific Considerations

  • Ultrasound should not be used for PCOS diagnosis in those <8 years after menarche due to high incidence of multi-follicular ovaries 3
  • Diagnostic thresholds should be revised regularly with advancing ultrasound technology 3

Monitoring and Follow-up

  • Regular assessment of metabolic parameters (glucose, lipids, blood pressure)
  • Monitoring for endometrial hyperplasia in untreated patients with irregular cycles
  • Evaluation of treatment efficacy for symptom control
  • Screening for cardiovascular risk factors

By following this evidence-based approach to blood workup and management, clinicians can effectively diagnose and treat patients with PCOS identified on ultrasound, potentially improving both short-term symptoms and long-term health outcomes.

References

Guideline

Diagnosis and Management of Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Which hormone tests for the diagnosis of polycystic ovary syndrome?

British journal of obstetrics and gynaecology, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.